Prosecution Insights
Last updated: October 01, 2026

The Curators of the University of Missouri

Technology area: Biotechnology & Pharmaceuticals

30 pending office actions • 24 art units • 29 examiners • 0 of 30 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Analysis

The Curators of the University of Missouri currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to a distinct examiner and a distinct art unit, indicating a highly concentrated prosecution focus at this time.

The busiest examiner for this portfolio is HILL, GRACELYN MARKHAM, who is responsible for the 1 busiest examiner pending action. This alignment between the total pending workload and the responsibility of a single examiner suggests a streamlined interaction with the patent office for the current filing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

30
Total Pending OAs
22
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
5
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (5)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

19
Hard (63%)
8
Medium (27%)
3
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (3%)
§101 + other1 (3%)
§103 only1 (3%)
§102 only2 (7%)
§112 only3 (10%)
Double-patenting + other5 (17%)
Multi-statute (no §101)17 (57%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
63% of docket
0
Information Tech
0% of docket
1
Communications
3% of docket
2
Semiconductors
7% of docket
5
Mechanical / Eng
17% of docket
3
Business / Other
10% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

300 h
Manual time on pending OAs
60 h
Time saved (low, 20%)
105 h
Time saved (mid, 35%)
2.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZHONG, WAYNESHAOBIN 2 72.2% +21.5%
TRUONG, KATELYN T 1 57.0% +37.6%
SCHUBERG, LAURA J 1 23.6% +37.0%
PENNINGTON, KATIE LEIGH 1 29.7% +60.0%
RAEVIS, ROBERT R 1 83.3% +15.3%
AHMED, SHAHED 1 90.8% -0.1%
MAEWALL, SNIGDHA 1 58.8% +10.5%
QIAN, SHIZHI 1 61.8% +47.9%
WILLIAMS, KEITH RICHARD 1 50.0% +0.0%
KELLY, ROBERT M 1 74.1% +24.6%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18713587 MODULAR BLAST PROBE RAEVIS, ROBERT R —
18641707 DIODE AND METHOD OF MAKING THE SAME AHMED, SHAHED —

Hard Cases (21)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18355971 COMPLIANT ROLLER CUTTER PRONE, JASON D 163d overdue
18548657 SUPPRESSION OF COVID-19 REPLICATION BY COVID-19 ENTRY INHIBITORS WHITE, DAWANNA SHAR-DAY 12d
18194691 ANKYRIN-RICH BTB/POZ DOMAIN-CONTAINING PROTEIN-2 (ABTB2) FOR SUPPRESSING PANCREATIC CANCER GROWTH SPENCER, ANDREA LYNNE MORRIS 20d
19230874 AUTOMATED INSECT DETECTION AND RESPONSE PRESCRIPTION TRUONG, KATELYN T 21d
17970095 POINT-OF-CARE ASSESSMENT SYSTEM CERIONI, DANIEL LEE 33d
19050638 TISSUE DECONTAMINATION AND PRESERVATION SYSTEM SCHUBERG, LAURA J —
19005128 PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES PENNINGTON, KATIE LEIGH —
18642226 LIGNIN-CONTAINING NANOCELLULOSE AND AG-AU-AG-CL NANOHYBRID AND GREEN FORMATION METHOD MAEWALL, SNIGDHA —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19230874 AUTOMATED INSECT DETECTION AND RESPONSE PRESCRIPTION TRUONG, KATELYN T 21d
18465802 INCREASING PLANT OIL CONTENT BY IMPROVING ACTIVITY OF ACETYL-COA CARBOXYLASE ZHONG, WAYNESHAOBIN 21d
19092212 METHODS OF ALTERING SEED WEIGHT AND SEED OIL CONTENT BY MANIPULATING ALPHA-CARBOXYL-TRANSFERASE (A-CT) ACTIVITY VIA CARBOXYL-TRANSFERASE INTERACTION (CTI) PROTEIN EXPRESSION ZHONG, WAYNESHAOBIN —
19050638 TISSUE DECONTAMINATION AND PRESERVATION SYSTEM SCHUBERG, LAURA J —
19005128 PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES PENNINGTON, KATIE LEIGH —
18713587 MODULAR BLAST PROBE RAEVIS, ROBERT R —
18642226 LIGNIN-CONTAINING NANOCELLULOSE AND AG-AU-AG-CL NANOHYBRID AND GREEN FORMATION METHOD MAEWALL, SNIGDHA —
18684297 MXENE-GRAPHENE FIELD EFFECT TRANSISTOR VIRUS SENSOR QIAN, SHIZHI —

Top Art Units

Art UnitApps
1662 2
1732 2
1631 2
3647 1
1634 1
2855 1
2813 1
1612 1
1663 1
1638 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19230874 AUTOMATED INSECT DETECTION AND RESPONSE PRESCRIPTION TRUONG, KATELYN T 3647 §102§103 Final Rejection 21d Pending Jun 06, 2025
19092212 METHODS OF ALTERING SEED WEIGHT AND SEED OIL CONTENT BY MANIPULATING ALPHA-CARBOXYL-TRANSFERASE (A-CT) ACTIVITY VIA CARBOXYL-TRANSFERASE INTERACTION (CTI) PROTEIN EXPRESSION ZHONG, WAYNESHAOBIN 1662 §112DP Non-Final OA — Pending Mar 27, 2025
19050638 TISSUE DECONTAMINATION AND PRESERVATION SYSTEM SCHUBERG, LAURA J — §103§112DP Non-Final OA — Pending Feb 11, 2025
19005128 PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES PENNINGTON, KATIE LEIGH 1634 §102§103§112DP Non-Final OA — Pending Dec 30, 2024
18713587 MODULAR BLAST PROBE RAEVIS, ROBERT R 2855 §112 Final Rejection — Pending May 24, 2024
18641707 DIODE AND METHOD OF MAKING THE SAME AHMED, SHAHED 2813 §102 Non-Final OA — Pending Apr 22, 2024
18642226 LIGNIN-CONTAINING NANOCELLULOSE AND AG-AU-AG-CL NANOHYBRID AND GREEN FORMATION METHOD MAEWALL, SNIGDHA 1612 §103§112 Non-Final OA — Pending Apr 22, 2024
18684297 MXENE-GRAPHENE FIELD EFFECT TRANSISTOR VIRUS SENSOR QIAN, SHIZHI — §103 Non-Final OA — Pending Feb 16, 2024
18530812 GENETIC MARKERS AND SOYBEAN PLANTS WITH INCREASED TOLERANCE TO DICAMBA WILLIAMS, KEITH RICHARD 1663 §112 Non-Final OA 12d Pending Dec 06, 2023
18511568 DYSTROPHIN CONSTRUCTS CONTAINING R11-R12 KELLY, ROBERT M 1638 §112DP Non-Final OA — Pending Nov 16, 2023
18501352 TASK-SPECIFIC IONIC LIQUIDS FOR SELECTIVE SEPARATION AND RECOVERY OF RARE EARTH ELEMENTS COHEN, STEFANIE J 1732 §102§103 Non-Final OA — Pending Nov 03, 2023
18378693 Three-Dimensional Lattice Batteries via Additive Manufacturing DIGNAN, MICHAEL L 1723 §103§112 Non-Final OA — Pending Oct 11, 2023
18554062 POLY(TETRAHYDROQUINAZOLINE) AND DERIVED CARBON AEROGELS KRYLOVA, IRINA 1764 §102§103Other Non-Final OA — Pending Oct 05, 2023
18554074 AMORPHOUS AND GRAPHITIC CARBON AEROGELS FROM COMPRESSED XEROGEL POWDERS BAREFORD, KATHERINE A 1732 §103§112 Non-Final OA — Pending Oct 05, 2023
18553231 EFFICIENT BIOCOMPATIBLE CRYOPRESERVATION MEDIUM THAT ELIMINATES THE NEED FOR CELL PERMEATING CRYOPROTECTANTS KOSAR, AARON J 1655 §102§103 Non-Final OA — Pending Sep 29, 2023
18472077 HIGH SPATIOTEMPORAL FIDELITY MRI SYSTEM UTILIZING SELF-SUPERVISED LEARNING WITH SELF-SUPERVISED REGULARIZATION RECONSTRUCTION METHODOLOGY AND ASSOCIATED METHOD OF USE ZAK, JACQUELINE ROSE 2666 §103§112 Non-Final OA — Pending Sep 21, 2023
18282139 TARGETED INSERTION VIA TRANSPOSITION NGUYEN, QUANG 1631 §103§112Other Non-Final OA — Pending Sep 14, 2023
18467310 EFFICIENT HEAT PUMP EJECTOR VACUUM DRYER TREMARCHE, CONNOR J. 3762 §103§112 Non-Final OA — Pending Sep 14, 2023
18465802 INCREASING PLANT OIL CONTENT BY IMPROVING ACTIVITY OF ACETYL-COA CARBOXYLASE ZHONG, WAYNESHAOBIN 1662 §112Other Final Rejection 21d Pending Sep 12, 2023
18548657 SUPPRESSION OF COVID-19 REPLICATION BY COVID-19 ENTRY INHIBITORS WHITE, DAWANNA SHAR-DAY 1627 §102§103 Final Rejection 12d Pending Sep 01, 2023
18365176 HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION WARD, AARON DUREL 1636 §103§112 Non-Final OA — Pending Aug 03, 2023
18363520 METHOD FOR SELECTING ANTIGENIC VIRAL SEQUENCES FOR VACCINES AND THERAPEUTICS LY, KRISTINA ELISABETH 1671 §103§112 Non-Final OA — Pending Aug 01, 2023
18363429 NERVE AGENT DECONTAMINATING AGENTS SZNAIDMAN, MARCOS L 1628 §102 Non-Final OA — Pending Aug 01, 2023
18355971 COMPLIANT ROLLER CUTTER PRONE, JASON D 3724 §103§112 Non-Final OA 163d overdue Pending Jul 20, 2023
18194691 ANKYRIN-RICH BTB/POZ DOMAIN-CONTAINING PROTEIN-2 (ABTB2) FOR SUPPRESSING PANCREATIC CANCER GROWTH SPENCER, ANDREA LYNNE MORRIS 1631 §103§112 Final Rejection 20d Pending Apr 03, 2023
18182846 RISK STRATIFICATION METHOD FOR THE DETECTION OF CANCERS IN PRECANCEROUS TISSUES FONSECA LOPEZ, FRANCINI ALVARENGA — §101§102§103§112 Non-Final OA — Pending Mar 13, 2023
17970095 POINT-OF-CARE ASSESSMENT SYSTEM CERIONI, DANIEL LEE 3791 §103§112 Final Rejection 33d Pending Oct 20, 2022
17961761 NANOPARTICLE IMMUNOCONJUGATES HUYNH, PHUONG N 1641 §112DP Final Rejection — Pending Oct 07, 2022
17782717 PROTEIN BLOCKING ASSEMBLY AND METHODS OF MAKING AND USING ALLEN, MARIANNE P 1654 §102§112 Non-Final OA — Pending Jun 06, 2022
17278835 MODEL-BASED SENSOR TECHNOLOGY FOR DETECTION OF CARDIOVASCULAR STATUS HOUGH, JESSANDRA F 3796 §101 Final Rejection — Pending Mar 23, 2021

Managing The Curators of the University of Missouri's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month